Chargement en cours...
Alemtuzumab-induced elimination of HIV-1-infected immune cells
BACKGROUND: : Currently, there is no drug known that is able to eradicate either HIV or HIV-infected host cells. The effectiveness of all available treatments is based on the prevention of viral replication. We investigated whether the monoclonal, CD52 receptor-targeting antibody, alemtuzumab, which...
Enregistré dans:
| Publié dans: | J Virus Erad |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mediscript Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946689/ https://ncbi.nlm.nih.gov/pubmed/27482429 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|